Thymosin Alpha-1 5 mg
34,90 €
Thymosin Alpha-1 5 mg is a synthetic acetylated thymic research peptide supplied as a lyophilized powder. It is a 28-amino-acid peptide studied in connection with thymic biology, T-cell-related signaling, innate immune pathways and wider immunoregulatory research.
Key product information:
- Compound: Thymosin Alpha-1
- Amount: 5 mg
- Form: Lyophilized powder
- Class: Acetylated 28-amino-acid thymic peptide
- Intended use: Research use only
- Description
- Additional information
Description
A Defined Thymic Peptide with a Long Immune-Research History
Thymosin Alpha-1 has a relatively simple origin story. It was first discovered in material taken from the thymus, an organ that plays an important role in the development of the immune system.
At the beginning, scientists were working with a mixture containing many different substances. Over time, they managed to identify one specific peptide made of 28 amino acids. This peptide became known as Thymosin Alpha-1.
Once its exact structure was known, researchers could produce and study the same defined molecule instead of relying on a complicated natural mixture.
From a Mixture to One Defined Peptide
Early thymus research did not begin with one clear molecule. Scientists were trying to understand which parts of the original mixture were responsible for the immune-related observations they were seeing.
Thymosin Alpha-1 became one of the most interesting components because it could be separated, identified and studied on its own.
This opened the door to more focused research involving immune cells, communication between different parts of the immune system and the way the body responds to infection, inflammation and other forms of stress.

Why It Attracts Attention
The thymus helps prepare and guide T cells, which are an important part of the immune system. Because Thymosin Alpha-1 was originally linked with thymic tissue, researchers became interested in how it may relate to immune-cell development and immune balance.
Its research story later expanded into areas involving infection, inflammation, immune responses and cancer-related research.
However, calling it an “immune booster” would be too simple. The immune system does not always need to be pushed harder. In some situations, the more important question is how immune activity is controlled, balanced and directed. For this reason, Thymosin Alpha-1 is more accurately described as an immunoregulatory research peptide – a peptide studied for its possible connection with the way different parts of the immune system communicate and respond.
Future Research Potential
Future research may help explain how Thymosin Alpha-1 is connected with immune regulation during infection, prolonged immune stress and cancer-related conditions.
Scientists are also studying why its signaling profile may differ across immune environments and which immune-cell responses are most consistently associated with it.
Important Notice
For research use only. Not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications. Before use, carefully review the Safety Data Sheet (SDS/MSDS – KBU). Intended only for experienced researchers and professionals familiar with the safe handling of research-grade materials.
Technical Questions (FAQ)
Thymosin Alpha-1 was originally identified in material obtained from the thymus. The thymus is an organ that plays an important role in the development of T cells, which form part of the immune system.
No. It is a clearly defined peptide made of 28 amino acids.
No. It is intended only for controlled research use and is not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications.
Lyophilization removes water from the material and helps maintain stability during storage. Exact storage, handling and preparation of the solution should always follow the product documentation and Safety Data Sheet.
Scientific Studies and Development Sources
Additional information
| CAS | 62304-98-7 |
|---|







